Total Visits

Views
Aberrant regulation of the GSK-3b/NRF2 axis unveils a novel therapy for adrenoleukodystrophy182

Total Visits Per Month

June 2021July 2021August 2021September 2021October 2021November 2021December 2021
Aberrant regulation of the GSK-3b/NRF2 axis unveils a novel therapy for adrenoleukodystrophy1000780

File Visits

Views
027662.pdf275

Top country views

Views
United States109
Germany14
China12
Spain4
Russia2
Ukraine2
Canada1
Switzerland1
United Kingdom1
Georgia1

Top cities views

Views
Fairfield32
Woodbridge30
Houston10
Cambridge8
Wilmington8
Shenzhen7
Kiez6
San Francisco6
Ann Arbor5
Ilmenau5